A consultancy service for all commercialising early stage technology opportunities


Specialising in working with research rich organisations (typically; universities, research institutes, start-up and SME companies) to help identify the commercial potential of their knowledge and skills and optimising the overall business plan.

Board level support

Board level support

Over 25 years of experience as a company director sitting on the Boards of 11 companies

Read More
Intellectual property strategy support

Intellectual property strategy support

IP management system creation and implementation of strategic commercial IP activity

Read More
Business development support

Business development support

Identifying potential customers, negotiation of partnership and collaboration agreements

Read More
Dr Pete Hotten

Dr Pete Hotten

Nuage Vision, founded by Dr Pete Hotten, was created to energize innovation in the life science and biotechnology sectors.

With 25 years’ operating at senior levels Pete has worked in the university, private and public sectors and has a proven ability for creating companies, introducing and implementing new strategies for maximising entrepreneurial capability and value of technology and intellectual property assets.

Pete has been privileged to have worked with outstanding academic institutions and research groups, created and engaged with many companies, and interacted with a diverse set of investors as well as being an investor in early-stage tech opportunities.

About Pete

" I have known Pete Hotten for many years and have seen him in many roles, but how I think of him as the master at getting the best out of intellectual property. Whether it is in the form of developing an IP strategy or in negotiating a favourable deal through the licensing of that technology"

Bruce Savage
GFC Diagnostics Ltd

“Pete helped raise the awareness of IP in the organisation and provided valuable input around integrating IP processes, thinking and management systems; the business continues to build upon these foundational elements as we strengthen our commercial and technical capabilities”

Robert Sherville-Payne
General Counsel, Medicines Discovery Catapult

“It was a pleasure to work with Pete who provided sound advice, particularly on IP matters such as freedom-to-operate and competitor analysis in the early stages of 4D BioMaterials”

Philip Smith
CEO, 4D Biomaterials